View the ASUMALIFE registration information details.
Back to drug list
ItemsDrug Registration information
ID1836
No1836
Brand NameASUMALIFE
IngredientsKETOTIFEN FUMARATE 1.38 MG EQ TO KETOTIFEN 1 MG/ 5ML
Dosage FormSYRUP
Primary PackagingBOTTLE
Storage
Shelf Life2 YEARS
Pack SizeBOX OF 100 ML/BOTTLE
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsPROPHYLACTIC TREATMENT OF BRONCHIAL ASTHMA AND SYMPTOMATIC TREATMENT OF ALLERGIC RHINITIS, DERMATITIS, URTICARIA AND PRURITUS. IT IS NOT EFFECTIVE IN ABORTING ESTABLISHED ATTACKS OF ASTHMA
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionA CLEAR, COLORLESS SOLUTION WITH PINEAPPLE FLAVOR
Note
License OwnerMEMESCO CO.,LTD
ManufacturerY.S.P. INDUSTRIES (M) SDN.BHD
CountryMALAYSIA
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No01 I 3421/10
FDD Registration Date07/06/2023
Expiry Date06/06/2026
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA